5-(Pyridin-2-yl)-1H-indazole

Catalog No.: 
ACVWTM696
CAS No.: 
885272-51-5
Molecular Formula: 
C12H9N3
Molecular Weight: 
195.23
5-(Pyridin-2-yl)-1H-indazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$330.00InquiryInquiry
250mg97%$594.00InquiryInquiry
1g97%$1828.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Pyridin-2-yl)-1H-indazole
IUPAC Name5-(pyridin-2-yl)-1H-indazole
Molecular FormulaC12H9N3
Molecular Weight195.23
SMILESC12=C(NN=C2)C=CC(C3=NC=CC=C3)=C1
InChI KeyWIRAQILXOCCSRB-UHFFFAOYSA-N
Synonym5-PYRIDIN-2-YL-1H-INDAZOLE;1H-Indazole, 5-(2-pyridinyl)-
CAS No.885272-51-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVWTM696 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJMDW417 route compound structure diagram
    ACJMDW417465529-55-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVWTM696 route product structure diagram
    ACVWTM696885272-51-5
Inquiry

2. ACVWTM696 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJMDW417 route compound structure diagram
    ACJMDW417465529-55-9In Stock
  2. Plus
  3. ACOJZD165 route compound structure diagram
    ACOJZD165197958-29-5In Stock
  4. Then
  5. ACVWTM696 route product structure diagram
    ACVWTM696885272-51-5
Inquiry

3. ACVWTM696 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJMDW417 route compound structure diagram
    ACJMDW417465529-55-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVWTM696 route product structure diagram
    ACVWTM696885272-51-5
Inquiry

Comments (0)